Tech Company M&A Transactions
Thrive Earlier Detection Acquisition
Thrive Earlier Detection, operating out of Cambridge, was acquired by EXACT Sciences. The acquisition price was $2.2 billion.
Transaction Overview
Company Name
Acquired By
Announced On
10/28/2020
Transaction Type
M&A
Amount
$2,150,000,000
M&A Terms
Thrive will get $1.7 billion, comprising 65% of Exact Sciences' common stock and 35% in cash, under terms of the deal. An additional $450 million is payable upon completion of certain milestones.
Company Information
Company Status
Acquired or Merged
Industry
Healthcare IT
Mailing Address
38 Sidney St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Thrive Earlier Detection Corp. is a healthcare company focused on incorporating earlier cancer detection into routine medical care to extend and save lives. Thrive is developing CancerSEEK, a liquid biopsy test that is designed to detect many cancers at earlier stages of disease that will serve as the core of its integrated cancer information offering.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Daly
Chief Financial Officer
Isaac Ro
Chief Operating Officer
Christoph Lengauer
VP - Bus. Development
Matthew Franklin
VP - General Counsel
Dina Ciarimboli
VP - Human Resources
Semi Trotto
VP - Product Management
Geoff Otto
VP - R & D
Isaac Kinde
VP - Regulatory Affairs
Seema Bhan
Browse more venture capital transactions:
Prev: 10/28/2020: Theta Lake venture capital transaction
Next: 10/28/2020: SimilarWeb venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs